Advertisement
Novel methodology shows extremes of age associated with lower post-transplant survival
EBUS-TBNA found safe and effective
An important biomarker in left heart failure
Younger patients respond better to endothelin receptor blockers
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Increase signals disease progression
An aggressive strategy falls short
Benefits could extend to patients with COPD
Research needed to fill critical knowledge gaps
HDL-C and outcomes in CTEPH
RAP/PAWP ratio as predictor of survival in patients with PAH
Advertisement
Advertisement